My tired, achey hips stopped me from sleeping — here's the doctor-approved routine that saved me
Recently, my tight hips (and my 17-month-old son) have been keeping me up at night, so I tried this doctor-approved routine to relieve the tension. Read on to find out more.
Your hip flexors are the group of muscles responsible for bending at the hip. If you spend a lot of time sitting down, these muscles can get tight, which can cause discomfort in your lower back, around your hips and potentially in your knees.
If your hips are tight, they'll pull your pelvis down and forward, referred to as an anterior pelvic tilt. This causes your lower back to arch, and can leave you feeling stiff and uncomfortable.
Another reason you might suffer from tight hip flexors is if you do certain types of repetitive exercises, including running and cycling. You use your hip flexor muscles to pull your thigh up as you run, so over time, this repetitive motion can lead to tightness.
Finally, having a weak core can lead to tightness in your hips, as if your deep abdominal muscles aren't stabilizing your spine when you move, your hip flexor muscles will take over.
As well as causing tightness and discomfort, weak hip flexors can cause foot and ankle issues and injuries, as the misalignment can travel down the leg, leading to issues like over-pronation and bunions.
Get instant access to breaking news, the hottest reviews, great deals and helpful tips.
I stumbled across this doctor-approved routine for tight hips and decided I had nothing to lose. The results after a couple of days shocked me.
The exercise, known as the corkscrew stretch, shared by Chiropractic Doctor Michael Rowe, helps you 'unlock tight achey hips in seconds.' Here's how to do the exercise:
After a few days of adding this deep stretch to my routine, my hips felt a lot more comfortable. I hadn't realised how tight my glutes had gotten as I got back into running postpartum, and how this tightness was affecting my hips as I returned to work, spending hours sitting behind my desk.
As a reminder, if you're experiencing severe hip pain, or hip pain that's lasted for weeks or is stopping you from doing your daily activities, it's always worth seeing a doctor or physiotherapist. If at any point during this exercise you feel stabbing pain, stop and seek medical advice.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
Formerly bankrupt weight-loss company makes a comeback
When it comes to things that most concern Americans about their health, weight loss is often at the top of the list. While America doesn't have the top obesity rate in the world, it does rank high on the list. More than 45% of Americans are obese. But the issue is bigger than just in the country - the worldwide rate of adult obesity has more than doubled since 1990, per the World Health Organization. Don't miss the move: Subscribe to TheStreet's free daily newsletter Attempts to solve this problem have spawned a thriving diet industry, always promoting the next pill, diet plan, or weight-loss gimmick to those desperate to attain better health. These approaches have all propelled the U.S. weight-loss market to grow over the decades, but the birth of GLP-1 drugs such as Ozempic sent it to new heights in 2023, with a market value of $90 billion. Related: One of Oprah's favorite things prepares for Chapter 11 bankruptcy It's a profitable market, but also an overcrowded one, and trying to get people's attention and stay on the cutting edge of what appeals to consumers presents a daunting challenge that businesses must continually navigate. Now, after one of the best-known names in the industry seemed to be on the edge of extinction, it's making a turnaround that few could have predicted - and with a new focus on a long-ignored women's issue. After declaring Chapter 11 bankruptcy in May of 2025, once-giant WeightWatchers (rebranded to WW beginning in 2018) admitted its $1.5 billion in debt was too big of a burden to continue to bear. The bankruptcy process would eliminate that debt, the company said, and it expected to reemerge as a publicly traded company. "The decisive actions we're taking today, with the overwhelming support of our lenders and noteholders, will give us the flexibility to accelerate innovation, reinvest in our members, and lead with authority in a rapidly evolving weight management landscape," said CEO Tara Comonte in a release at the time. Related: WeightWatchers takes drastic step to exit bankruptcy WeightWatchers made its debut in the '60s, at a time when diet and portion control were a focus, and enjoyed many decades of success. The company also got a significant boost when Oprah partnered with it in 2015. WeightWatchers has now emerged from that bankruptcy with a new focus: helping middle-aged women struggling with all stages of menopause, from peri to post. The new program will offer access to prescription treatments such as hormone replacement therapy and also help women connect with resources for behavioral and nutritional support, WeightWatchers said. The company also named Dr. Kim Boyd as its new chief medical officer. Boyd has worked in leadership at One Medical, Calibrate, Caire, Galileo, and Nurx in the past and has co-founded or scaled multiple consumer health companies. Menopause care has been a hot topic as of late, with high-profile actresses such as Naomi Watts founding new companies to support women going through it. After Watts experienced early menopause at 36, she founded Stripes Beauty, a brand that sells products aimed at women in all stages of the life change. WW's new angle could provide the first large-scale platform for menopausal women, which could take advantage of a once-taboo topic that's slowly gained more attention in recent years. Related: Red-hot weight-loss drug stock tanks after surprise pharma giant decision The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
The Hill
an hour ago
- The Hill
In reversal, Trump administration will defend Biden's asbestos ban
The Trump administration says it will uphold a Biden-era ban on the ongoing use of asbestos after previously saying it would reconsider the rule. In a court filing last month, the Environmental Protection Agency (EPA) had said that it planned to pursue a rulemaking process that could make changes to the ban. However, in a Monday court filing, it withdrew that previous motion, saying it 'no longer intends to conduct … rulemaking to evaluate potential changes at this time.' In an additional court filing, Lynn Dekleva, an official in the EPA's Office of Chemical Safety and Pollution Prevention, said that the administration could try to instead use a guidance to alter how the rule is implemented. 'EPA plans to explore whether guidance could provide further clarity to stakeholders as they implement the Rule, particularly with respect to any workplace protection measures,' Dekleva's declaration states. But the declaration means that the Trump administration will defend the asbestos ban in court after challenges from the chemical industry and others. The Biden-era rule requires companies to phase out their uses of a type of asbestos known as chrysotile asbestos, which is the only known type used in the U.S. The rule gave companies making automotive breaks six months to stop making products with asbestos, while other industries got more time. Most sheet gaskets, a type of seal, that contain asbestos will be banned after two years, while the chlor-alkali sector, which makes chemicals like chlorine for treating water, will have up to 12 years to make the change. Exposure to asbestos causes lung cancer and mesothelioma, a rare cancer that occurs in the lining of the lung, chest and the abdomen and heart. Asbestos-related diseases are estimated to kill thousands of Americans each year. Michelle Roos, executive director of the Environmental Protection Network, a group of former EPA employees, called the administration's latest court filing a 'step in the right direction' in a written statement, saying it came in the wake of 'fierce public pressure and legal accountability. 'This is just the beginning of the public backlash against the Trump administration's plans to roll back 31 standards that protect the air we breathe and the water we drink,' Roos said. A number of Trump administration officials have ties to the chemical industry, including the agency's deputy administrator, who represented a group of car companies that argued against the asbestos ban in a legal filing last year.
Time Business News
an hour ago
- Time Business News
Behind the Wheel and Under the Influence: What Driving Data Reveals About America's Cannabis Shift
As the legalization of recreational cannabis spreads across the country, a new concern is emerging on America's highways. According to a study published by The Texas Law Dog, states where cannabis is legal for recreational use are reporting a concerning rise in car crashes and road fatalities. These trends suggest that the push for cannabis freedom may be unintentionally fueling a public safety crisis. Legalization on the Rise, So Are Crashes In 2011, recreational marijuana was illegal nationwide. As of 2025, 25 states allow adult-use cannabis, and the results on roadways are becoming harder to ignore. The Texas Law Dog's report found that the widespread legalization of marijuana is linked to a 6% increase in motor vehicle crashes and a 4% increase in fatal crashes nationwide. Individual state data provides even starker illustrations. In Oregon, crash fatalities have increased by 22% since legalization. Alaska and Colorado have seen fatal crash spikes of 20% and 16%, respectively, while California reports a 14% rise. These increases aren't isolated they're part of a growing national trend. Cannabis and Driving: A Deadly Mix As marijuana becomes more accessible, its use is also becoming more casual. By 2019, nearly one in five Americans aged 12 or older reported using cannabis up from just 11% in 2002. More troubling is that a significant portion of users are taking to the roads while impaired. The Texas Law Dog analysis revealed that 85% of cannabis users admit to driving the same day they consume the drug, with over half doing so within an hour. These findings are critical, given marijuana's well-documented impact on reaction time, attention, and coordination. Cannabis is also emerging as a dominant factor in fatal crashes. During the COVID-19 pandemic, cannabis involvement in fatal accidents surpassed alcohol for the first time accounting for 33% of deaths compared to alcohol's 29%. The Challenge of Poly-Substance Use The threat of cannabis-impaired driving becomes more complex when other substances are involved. The study highlights that pre-pandemic, 18% of drivers involved in fatal crashes had multiple drugs in their systems. Post-pandemic, that figure climbed to 25%. This trend poses challenges not just for enforcement, but also for toxicology and crash analysis. Determining whether cannabis was the primary impairment in such cases becomes increasingly difficult when alcohol or other drugs are also present. A Tale of Two Policies: Medical vs. Recreational Interestingly, not all cannabis laws have had the same effect on public safety. States with legalized recreational cannabis saw a 4–6% increase in crash rates. Meanwhile, states with only medical cannabis programs experienced a reduction in traffic fatalities between 8% and 11%. This discrepancy may stem from how cannabis is distributed and consumed in these states. Recreational laws tend to widen access without the same medical oversight, potentially leading to more frequent and unregulated use by the general public. A False Sense of Security Behind the Wheel One of the most revealing aspects of The Texas Law Dog's findings is the disconnect between perceived and actual risk. While 70% of users said driving within an hour of cannabis use was 'highly dangerous,' and 93% believed their friends or family would disapprove, many still drive high. Why the contradiction? Nearly 30% of users believe law enforcement wouldn't be able to detect their impairment. With limited roadside tools to measure THC levels and no national threshold for cannabis DUI, many drivers feel they can get away with it. The Legal Patchwork Fuels Public Confusion Differences in cannabis laws from state to state only add to the problem. In Alaska, recreational users can carry up to one ounce, but medical users may possess up to 2.5 ounces every two weeks. In California, medical patients are allowed eight ounces. In some states, like Idaho and Nebraska, all cannabis possession is still illegal. This legal inconsistency creates a minefield of confusion for both law enforcement and drivers, especially those crossing state lines. Uniform standards on THC limits and impaired driving penalties could go a long way in closing these gaps. Solutions That Balance Freedom and Safety Legalizing cannabis doesn't have to mean compromising traffic safety. The Texas Law Dog study calls for a smarter approach to impaired driving prevention. Among the proposed strategies: Development of reliable roadside THC testing Standardized DUI laws across state lines Expanded public education on cannabis impairment Stronger restrictions on driving post-use Increased funding for drug-impaired driving research States that legalize cannabis should do so with a parallel commitment to traffic safety. That includes investing in law enforcement training, refining legislation, and ensuring that public messaging keeps up with the pace of policy reform. Conclusion: Freedom Without Responsibility Isn't Freedom at All The movement toward cannabis legalization shows no signs of slowing, but the data shows a clear cost: more crashes, more deaths, and more uncertainty on the road. The Texas Law Dog's study reveals a growing risk that demands a balanced, evidence-based response. As lawmakers navigate the future of drug policy, ensuring public safety must remain part of the equation. Because every right, including the right to use cannabis, carries a responsibility especially when lives are on the line. TIME BUSINESS NEWS
